Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
The analgesics market in Bulgaria has reached a mature stage, characterised by steady growth and well-established product offerings. This maturity is evident in the consistent demand for pain relief solutions driven by factors such as an ageing…
Consumers are increasingly embracing self-medication, especially for minor illnesses, and this contributed to modest growth in 2023, as well as continuing population growth. Analgesics have achieved a substantial penetration rate in Cameroon,…
Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…
In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…
Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…
After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…
Rising inflation has caused consumers to be increasingly stressed in 2023, with rising price points and ongoing economic uncertainty negatively impacting lives. This ongoing uncertainty has led to an increase in physical discomforts; often in the…
Growth of analgesics in 2023 can be mainly attributed to the full recovery of daily activity post pandemic. The main contributors here were the full operation of manual labour intensive industries (predominantly construction), a stronger flu season…
Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…
Analgesics has not seen a positive performance in 2023 as the height of the pandemic has passed. During the pandemic’s peak, consumers were buying up analgesics at a rapid pace to treat fevers, aches and other symptoms associated with acute…